Huang et al., 1958 - Google Patents
MECHANISM AND TREATMENT OF CARDIAC ARRHYTHMIAS IN TARTAR EMETIC INTOXICATION: WITH SPECIAL REFERENCE TO ATROPINE THERAPYHuang et al., 1958
View PDF- Document ID
- 15652742774115269645
- Author
- Huang M
- Chiang S
- P'an J
- Yü K
- Lu C
- HSÜ C
- Kao W
- Publication year
- Publication venue
- Chinese Medical Journal
External Links
Snippet
Numerous new chemical compounds for the treatment of schisto-somiasis have been synthesized in recent years, but none has been found to surpass the old yet effective drug tartar emetic. A serious disadvantage of tartar emetic is its severe toxicity. The therapeutic …
- 208000005374 Poisoning 0 title abstract description 9
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/362—Heart stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lister et al. | Atrioventricular conduction in man: Effect of rate, exercise, isoproterenol and atropine on the PR interval | |
| LEONARD | The use of diphenylhydantoin (Dilantin) sodium in the treatment of ventricular tachycardia | |
| Enselberg et al. | The effects of magnesium upon cardiac arrhythmias | |
| Morace et al. | Effect of isoproterenol on the “early repolarization” syndrome | |
| Birchfield et al. | Disease of the sinoatrial node associated with bradycardia, asystole, syncope, and paroxysmal atrial fibrillation | |
| Danilo Jr et al. | Effects of the phenothiazine analog, EN-313, on ventricular arrhythmias in the dog | |
| Wayne et al. | The effect of adenosine triphosphate on the electrocardiogram of man and animals | |
| Wittenberg et al. | Relationship of heart rate to ventricular automaticity in dogs during ouabain administration | |
| Milne et al. | The long QT syndrome: Effects of drugs and left stellate ganglion block | |
| Zapata-Díaz et al. | An experimental and clinical study on the effects of procaine amide (Pronestyl) on the heart | |
| Wedd et al. | The action of procaine amide on the heart | |
| Friedberg et al. | Adams-Stokes syndrome associated with chronic heart block: treatment with corticosteroids | |
| Binder et al. | Paroxysmal ventricular tachycardia and fibrillation due to quinidine | |
| Harris et al. | Treatment of slow heart rates following acute myocardial infarction | |
| Vassalle et al. | Effects of potassium on ouabain-induced arrhythmias | |
| YANAGIDA et al. | The effects of stellate ganglion block on the idiopathic prolongation of the QT interval with cardiac arrhythmia (the Romano-Ward syndrome) | |
| Burstein et al. | Protecting action of procaine against ventricular fibrillation induced by epinephrine during cyclopropane anesthesia | |
| Sandler et al. | Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia | |
| BURSTEIN et al. | Laboratory studies on the prophylaxis and treatment of ventricular fibrillation induced by epinephrine during cyclopropane anesthesia | |
| Huang et al. | MECHANISM AND TREATMENT OF CARDIAC ARRHYTHMIAS IN TARTAR EMETIC INTOXICATION: WITH SPECIAL REFERENCE TO ATROPINE THERAPY | |
| Goble | Paroxysmal ventricular fibrillation with spontaneous reversion to sinus rhythm | |
| URTHALER et al. | Selective effects of pentobarbital on automaticity and conduction in the intact canine heart | |
| Enselberg | The dying human heart: Electrocardiographic study of forty-three cases, with notes upon resuscitative attempts | |
| Greenspan et al. | Relationship between potassium and vagal action on atrioventricular transmission | |
| Allen et al. | Effects of lignocaine and propranolol on experimental cardiac arrhythmias |